C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/06 (2006.01) A61K 31/4178 (2006.01) A61P 29/00 (2006.01) C07D 403/14 (2006.01) C07D 405/14 (2006.01) C07D 417/14 (2006.01) C07D 471/04 (2006.01) C07D 491/048 (2006.01) C07D 513/04 (2006.01)
Patent
CA 2637198
This invention relates to compounds of the Formula (I), or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, TNF-.alpha. or combinations thereof.
Cette invention concerne des composés représentés par la formule (I), ou un sel, un solvate ou un isomère pharmaceutiquement acceptable de ceux-ci, lesquels peuvent être utiles pour le traitement de maladies et d'affections induites par MMP, ADAM, TACE, l'agrécanase, le TNF-.alpha. ou des combinaisons de ceux-ci.
Dai Chaoyang
Girijavallabhan Vinay M.
Kim Seong-Heon
Kozlowski Joseph A.
Lavey Brian J.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Schering Corporation
LandOfFree
Hydantoin compounds for the treatment of inflammatory disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydantoin compounds for the treatment of inflammatory disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydantoin compounds for the treatment of inflammatory disorders will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1742085